HealthStream Q3 net income falls 11.7% to $5.4M
HSTM's updated 2026 outlook includes revenue guidance of $331.0–$333.0 million and net income guidance of $21.8–$22.4 million.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
HealthStream, Inc. (HSTM) reported third-quarter 2026 revenue of $83.3 million, up 8.9% from $76.5 million. Operating income declined 13.0% to $6.6 million and net income declined 11.7% to $5.4 million; adjusted EBITDA, a non-GAAP measure, rose 1.0% to $19.3 million.
For the first nine months, revenue rose 10.6% to $248.2 million, operating income 25.7% to $22.4 million, net income 13.6% to $18.0 million and adjusted EBITDA 13.4% to $60.0 million. Updated 2026 guidance is revenue $331.0–$333.0 million, net income $21.8–$22.4 million, adjusted EBITDA $77.0–$78.0 million and capital expenditures $31.0–$34.0 million. The guidance assumes general economic conditions do not deteriorate.
On September 14, 2026, HealthStream issued 1,355,932 shares to WJRJJ Ventures, LLC in a private placement for approximately $40.0 million, or $29.50 per share. It intends to use net proceeds for general corporate purposes, including continued investment in its solutions, working capital, potential acquisitions and other strategic initiatives. The board declared a $0.035-per-share quarterly dividend, payable November 27, 2026, to holders of record November 16, 2026.
How this balance works
Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.
It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.
Rhea-AI Sentiment measures something else, the tone of the wording.
Positive
- Moderate pointThird-quarter revenue increased 8.9% to $83.3 million.
- Moderate pointNine-month operating income increased 25.7% to $22.4 million.
Negative
- Moderate pointThird-quarter operating income declined 13.0% to $6.6 million.
- Moderate pointThird-quarter net income declined 11.7% to $5.4 million.
Filing Explained
At September thirtieth, HealthStream reported cash, cash equivalents and marketable securities, and no borrowed-money debt.
The company repurchased 432,476 common shares for an aggregate fair value of
At
Updated full-year 2026 revenue guidance is higher than the prior range. Net-income guidance is higher than previously. Adjusted EBITDA guidance has a higher lower bound and an unchanged upper bound. The company calls this a guidance increase, but the adjusted EBITDA upper bound is unchanged; the revenue and net-income ranges each moved upward at both ends.
8-K Event Classification
Key Figures
Key Terms
Adjusted EBITDA financial
private placement financial
Deferred revenue financial
marketable securities financial
Earnings Snapshot
Updated 2026 guidance: revenue $331.0–$333.0 million; net income $21.8–$22.4 million; adjusted EBITDA $77.0–$78.0 million; capital expenditures $31.0–$34.0 million.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How did HSTM perform in the third quarter of 2026?
What were the terms of HSTM's private placement?
AI-generated analysis. How Rhea-AI works. Not financial advice.
|
|
|
|
|
(State or Other Jurisdiction of Incorporation)
|
(Commission File Number)
|
(IRS Employer Identification No.)
|
|
|
|
|
|
(Address of Principal Executive Offices)
|
(Zip Code)
|
|
Title of each Class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
|
|
|
|
|
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
|
Exhibit
Number
|
Description
|
|
|
99.1*
|
Press release dated November 2, 2026
|
|
|
104
|
Cover Page Interactive Data File (embedded within the Inline XBRL document).
|
|
*
|
Furnished herewith.
|
|
Exhibit
Number
|
Description
|
|
|
99.1*
|
Press release dated November 2, 2026
|
|
|
104
|
Cover Page Interactive Data File (embedded within the Inline XBRL document).
|
|
*
|
Furnished herewith.
|
|
HealthStream, Inc.
|
|||
|
Date: November 2, 2026
|
By:
|
/s/ Scott A. Roberts
|
|
|
Scott A. Roberts
|
|||
|
Chief Financial Officer
|
|||
|
HealthStream Announces Third Quarter 2026 Results Page 1 November 2, 2026 |
Exhibit 99.1
|
|
Contact: |
Scott A. Roberts |
|
|
Chief Financial Officer |
||
|
(615) 301-3182 |
||
|
ir@healthstream.com |
||
|
Media: |
||
|
Mollie Condra, Ph.D. |
||
|
Head, Investor Relations & Communications |
||
|
(615) 301-3237 |
||
|
mollie.condra@healthstream.com |
HEALTHSTREAM ANNOUNCES THIRD QUARTER 2026 RESULTS
NASHVILLE, Tenn. (November 2, 2026)—HealthStream, Inc. (the "Company") (Nasdaq: HSTM), a leading healthcare technology platform company for clinical workforce solutions, today announced results for the third quarter ended September 30, 2026.
Third Quarter 2026
|
• |
Revenues of $83.3 million, up 8.9% from $76.5 million in the third quarter of 2025 |
|
• |
Operating income of $6.6 million, down 13.0% from $7.6 million in the third quarter of 2025 |
|
• |
Net income of $5.4 million, down 11.7% from $6.1 million in the third quarter of 2025 |
|
• |
Earnings per share (EPS) of $0.18 per share (diluted), down from $0.20 per share (diluted) in the third quarter of 2025 |
|
• |
Adjusted EBITDA1 of $19.3 million, up 1.0% from $19.1 million in the third quarter of 2025 |
| • | Approximately $40 million of cash proceeds received through a private placement of HealthStream common stock | |
|
• |
Board of Directors declared a quarterly cash dividend of $0.035 per share, payable on November 27, 2026 to holders of record on November 16, 2026 |
Financial Results:
Third Quarter 2026 Compared to Third Quarter 2025
Revenues for the third quarter of 2026 increased by $6.8 million, or 8.9%, to $83.3 million, compared to $76.5 million for the third quarter of 2025. Subscription revenues increased by $6.2 million, or 8.0%, and professional services revenues increased by $0.7 million compared to the third quarter of 2025. Compared to the third quarter of 2025, revenue growth for the third quarter of 2026 was positively impacted by $3.2 million from our acquisitions of Virsys12 and MissionCare Collective completed during the fourth quarter of 2025 and $3.6 million from growth across our existing portfolio of solutions.
Operating income was $6.6 million for the third quarter of 2026, down 13.0% from $7.6 million in the third quarter of 2025. The decline in operating income was primarily attributable to higher operating expenses to support investments in several areas of the business, primarily in our platform and enterprise applications, including personnel costs, third-party software expenses, cloud hosting, and amortization expense from our fourth quarter 2025 acquisitions. In addition, operating income was impacted by expense of approximately $250,000 incurred during the third quarter of 2026 related to the cybersecurity incident disclosed by us on July 29, 2026, after giving effect to related insurance recoveries.
Net income was $5.4 million in the third quarter of 2026, down 11.7% from $6.1 million in the third quarter of 2025, and EPS was $0.18 per share (diluted) in the third quarter of 2026, down from $0.20 per share (diluted) in the third quarter of 2025.
1 Adjusted EBITDA is a non-GAAP financial measure. A reconciliation of adjusted EBITDA to net income and disclosure regarding why we believe adjusted EBITDA provides useful information to investors is included later in this release.
|
HealthStream Announces Third Quarter 2026 Results Page 2 November 2, 2026 |
|
Adjusted EBITDA was $19.3 million for the third quarter of 2026, up 1.0% from $19.1 million in the third quarter of 2025.
At September 30, 2026, the Company had cash, cash equivalents, and marketable securities of $115.2 million. The Company does not have any outstanding indebtedness of borrowed money. Capital expenditures incurred during the third quarter of 2026 were $7.5 million.
Year-to-Date 2026 Compared to Year-to-Date 2025
For the nine months ended September 30, 2026, revenues were $248.2 million, an increase of 10.6% over revenues of $224.4 million for the first nine months of 2025. Operating income for the first nine months of 2026 increased by 25.7% to $22.4 million, compared to $17.8 million for the first nine months of 2025. The increase in operating income was primarily attributable to higher revenues partially offset by higher expenses to support investments in several areas of the business, primarily in our platform and enterprise applications, resulting in higher labor costs, as well as higher third-party software, commissions expense, amortization expense from our fourth quarter 2025 acquisitions, royalties expense, and cloud hosting. Net income for the first nine months of 2026 increased by 13.6% to $18.0 million, compared to $15.8 million for the first nine months of 2025. Earnings per share were $0.61 per share (diluted) for the first nine months of 2026, compared to $0.52 per share (diluted) for the first nine months of 2025. Adjusted EBITDA increased by 13.4% to $60.0 million for the first nine months of 2026, compared to $52.9 million for the first nine months of 2025.
Other Business Updates
On March 13, 2026, the Company announced a new share repurchase program approved by the Board of Directors under which the Company was authorized to repurchase up to $10.0 million of its outstanding shares of common stock. This share repurchase program expired on September 12, 2026 in accordance with its terms. During the three months ended September 30, 2026, the Company did not repurchase any shares of common stock under this program.
During the first nine months of 2026, the Company repurchased 432,476 shares of common stock under previously authorized share repurchase programs at an aggregate fair value of $9.3 million, reflecting an average purchase of $21.50 per share (excluding the cost of broker commissions and the 1% share repurchase excise tax imposed by the Inflation Reduction Act of 2022).
On September 14, 2026, the Company issued 1,355,932 shares of its common stock to WJRJJ Ventures, LLC in a private placement for an aggregate cash purchase price of approximately $40.0 million, reflecting a price of $29.50 per share. The Company intends to use the net proceeds received from the issuance of these shares for general corporate purposes, including continued investment in its solutions, working capital, potential acquisitions, and other strategic initiatives.
On November 2, 2026, the Board of Directors approved a quarterly cash dividend under the Company's dividend policy of $0.035 per share, payable on November 27, 2026 to holders of record on November 16, 2026.
|
HealthStream Announces Third Quarter 2026 Results Page 3 November 2, 2026 |
|
Financial Outlook for 2026
The Company is updating its guidance for 2026 for the measures set forth below.
|
Full Year 2026 Guidance |
||||||||||
| Low | High | |||||||||
|
Revenue1 |
$ | 331.0 |
- |
$ | 333.0 |
million |
||||
|
Net Income2 |
$ | 21.8 |
- |
$ | 22.4 |
million |
||||
|
Adjusted EBITDA3 |
$ | 77.0 |
- |
$ | 78.0 |
million |
||||
|
Capital Expenditures |
$ | 31.0 |
- |
$ | 34.0 |
million |
||||
1 Previous expected Revenue guidance range was $327.0 to $332.0 million.
2 Previous expected Net Income guidance range was $19.5 to $22.2 million.
3 Previous expected Adjusted EBITDA guidance range was $74.0 to $78.0 million. Adjusted EBITDA is a non-GAAP financial measure. A reconciliation of projected adjusted EBITDA to projected net income (the most comparable GAAP measure) is included later in this release.
The Company’s guidance for 2026, as set forth above, reflects the Company’s assumptions regarding, among other things, expectations for new sales and renewals, and assumes that general economic conditions do not deteriorate. This guidance does not include the impact of any future acquisitions or dispositions that we may complete during 2026, gains or losses from changes in the fair value of non-marketable equity investments or contingent consideration, or impairment of long-lived assets.
Robert A. Frist, Jr., Chief Executive Officer, HealthStream, said, “Nine months into 2026, HealthStream has grown revenues 10.6%, operating income 25.7%, and adjusted EBITDA 13.4% compared to the same period last year. Our third quarter continued that progress, with revenues up 8.9% to $83.3 million, and we are raising our full-year guidance.”
CEO Frist continued, “The clinical healthcare workforce continues to grow, and healthcare organizations need better ways to find, develop, credential, schedule, onboard, and retain these professionals. Our hStream platform brings together verified healthcare professionals and students, healthcare organizations, and industry partners in one powerful ecosystem. The clinical workforce is the heartbeat of American healthcare, and HealthStream is building the infrastructure it runs on.”
A conference call with Robert A. Frist, Jr., Chief Executive Officer, Scott A. Roberts, Chief Financial Officer and Senior Vice President, and Mollie Condra, Head, Investor Relations & Corporate Communications, will be held on Tuesday, November 3, 2026, at 9:00 a.m. (ET). Participants may access the conference call live via webcast using this link: https://edge.media-serve.com/mmc/p/rrasd788. To participate via telephone, please register in advance using this link: https://register-conf.media-server.com/register/BI02855f88e0364e1883356079b21aef8e. A replay of the conference call and webcast will be archived on the Company’s website in the Investor Relations section under “Events & Presentations.”
|
HealthStream Announces Third Quarter 2026 Results Page 4 November 2, 2026 |
|
Use of Non-GAAP Financial Measures
This press release presents adjusted EBITDA, a non-GAAP financial measure used by management in analyzing the Company’s financial results and ongoing operational performance. In order to better assess the Company’s financial results, management believes that net income before interest, income taxes, stock-based compensation, depreciation and amortization, impairments of long-lived assets, changes in fair value of contingent consideration, changes in fair value of, including gains (losses) on the sale of, non-marketable equity investments, and expense related to the cybersecurity incident disclosed by us on July 29, 2026 (the “Cybersecurity Incident”), after giving effect to related insurance recoveries (“adjusted EBITDA”), is a useful measure for evaluating the operating performance of the Company because adjusted EBITDA reflects net income adjusted for certain GAAP accounting, non-cash, and/or non-operating items which may not, in any such case, fully reflect the underlying operating performance of our business. We believe that adjusted EBITDA is useful to investors to assess the Company’s ongoing operating performance and to compare the Company’s operating performance between periods. In addition, certain short-term cash incentive bonuses and performance-based equity awards are based on the achievement of adjusted EBITDA (as defined in applicable bonus and equity grant documentation) targets.
The Company has included an adjustment in the definition of adjusted EBITDA for the expense related to the Cybersecurity Incident incurred during the third quarter of 2026, after giving effect to related insurance recoveries, because the Company believes that this expense amount may not be reflective of the underlying operational performance of the Company’s business and that including this adjustment is consistent with the intended purpose of adjusted EBITDA of reflecting the underlying operating performance of the Company’s business and comparing the Company’s operational performance between periods.
Adjusted EBITDA is a non-GAAP financial measure and should not be considered as a measure of financial performance under GAAP. Because adjusted EBITDA is not a measurement determined in accordance with GAAP, adjusted EBITDA is susceptible to varying calculations. Accordingly, adjusted EBITDA, as presented, may not be comparable to other similarly titled measures of other companies and has limitations as an analytical tool.
Adjusted EBITDA should not be considered a substitute for, or superior to, measures of financial performance, which are prepared in accordance with GAAP. Investors are encouraged to review the reconciliations of adjusted EBITDA to net income (the most comparable GAAP measure), which is set forth below in this release.
About HealthStream
|
HealthStream Announces Third Quarter 2026 Results Page 5 November 2, 2026 |
|
HEALTHSTREAM, INC.
Condensed Consolidated Statements of Income
(In thousands, except per share data)
(Unaudited)
|
Three Months Ended |
Nine Months Ended |
|||||||||||||||
|
September 30, 2026 |
September 30, 2025 |
September 30, 2026 |
September 30, 2025 |
|||||||||||||
|
Revenues, net |
$ | 83,309 | $ | 76,474 | $ | 248,244 | $ | 224,355 | ||||||||
|
Operating costs and expenses: |
||||||||||||||||
|
Cost of revenues (excluding depreciation and amortization) |
30,010 | 26,507 | 86,784 | 78,357 | ||||||||||||
|
Product development |
13,525 | 12,107 | 40,712 | 36,228 | ||||||||||||
|
Sales and marketing |
13,320 | 12,143 | 39,783 | 36,101 | ||||||||||||
|
General and administrative |
8,602 | 7,330 | 24,641 | 23,396 | ||||||||||||
|
Depreciation and amortization |
11,265 | 10,820 | 33,905 | 32,441 | ||||||||||||
|
Total operating costs and expenses |
76,722 | 68,907 | 225,825 | 206,523 | ||||||||||||
|
Operating income |
6,587 | 7,567 | 22,419 | 17,832 | ||||||||||||
|
Interest income |
510 | 788 | 1,399 | 2,676 | ||||||||||||
|
Other expense, net |
(28 | ) | (103 | ) | (233 | ) | (141 | ) | ||||||||
|
Income before income tax provision |
7,069 | 8,252 | 23,585 | 20,367 | ||||||||||||
|
Income tax provision |
1,696 | 2,166 | 5,634 | 4,559 | ||||||||||||
|
Net income |
$ | 5,373 | $ | 6,086 | $ | 17,951 | $ | 15,808 | ||||||||
|
Net income per share: |
||||||||||||||||
|
Basic |
$ | 0.18 | $ | 0.20 | $ | 0.61 | $ | 0.52 | ||||||||
|
Diluted |
$ | 0.18 | $ | 0.20 | $ | 0.61 | $ | 0.52 | ||||||||
|
Weighted average shares of common stock outstanding: |
||||||||||||||||
|
Basic |
29,491 | 29,688 | 29,366 | 30,151 | ||||||||||||
|
Diluted |
29,656 | 29,811 | 29,465 | 30,283 | ||||||||||||
|
Dividends declared per share |
$ | 0.035 | $ | 0.031 | $ | 0.105 | $ | 0.093 | ||||||||
|
HealthStream Announces Third Quarter 2026 Results Page 6 November 2, 2026 |
|
HEALTHSTREAM, INC.
Condensed Consolidated Balance Sheets
(In thousands)
(Unaudited)
|
September 30, |
December 31, |
|||||||
|
2026 |
2025 |
|||||||
|
ASSETS |
||||||||
|
Current assets: |
||||||||
|
Cash and cash equivalents |
$ | 58,964 | $ | 36,161 | ||||
|
Marketable securities |
56,197 | 20,843 | ||||||
|
Accounts and unbilled receivables, net |
38,727 | 38,998 | ||||||
|
Prepaid and other current assets |
25,470 | 23,654 | ||||||
|
Total current assets |
179,358 | 119,656 | ||||||
|
Capitalized software development, net |
47,014 | 45,581 | ||||||
|
Property and equipment, net |
9,659 | 10,661 | ||||||
|
Operating lease right of use assets, net |
13,276 | 15,272 | ||||||
|
Goodwill and intangible assets, net |
269,130 | 282,448 | ||||||
|
Other assets |
47,414 | 46,756 | ||||||
|
Total assets |
$ | 565,851 | $ | 520,374 | ||||
|
LIABILITIES AND SHAREHOLDERS’ EQUITY |
||||||||
|
Current liabilities: |
||||||||
|
Accounts payable, accrued, and other liabilities |
$ | 29,328 | $ | 35,729 | ||||
|
Deferred revenue |
91,861 | 88,417 | ||||||
|
Total current liabilities |
121,189 | 124,146 | ||||||
|
Deferred tax liabilities |
23,449 | 18,246 | ||||||
|
Deferred revenue, noncurrent |
1,024 | 1,344 | ||||||
|
Operating lease liability, noncurrent |
12,777 | 14,684 | ||||||
|
Other long-term liabilities |
5,472 | 7,931 | ||||||
|
Total liabilities |
163,911 | 166,351 | ||||||
|
Shareholders’ equity: |
||||||||
|
Common stock |
265,266 | 231,797 | ||||||
|
Accumulated other comprehensive loss |
(1,794 | ) | (1,361 | ) | ||||
|
Retained earnings |
138,468 | 123,587 | ||||||
|
Total shareholders’ equity |
401,940 | 354,023 | ||||||
|
Total liabilities and shareholders' equity |
$ | 565,851 | $ | 520,374 | ||||
|
HealthStream Announces Third Quarter 2026 Results Page 7 November 2, 2026 |
|
HEALTHSTREAM, INC.
Condensed Consolidated Statements of Cash Flows
(In thousands)
(Unaudited)
|
Nine Months Ended |
||||||||
|
September 30, |
September 30, |
|||||||
|
2026 |
2025 |
|||||||
|
Operating activities: |
||||||||
|
Net income |
$ | 17,951 | $ | 15,808 | ||||
|
Adjustments to reconcile net income to net cash provided by operating activities: |
||||||||
|
Depreciation and amortization |
33,905 | 32,441 | ||||||
|
Stock-based compensation |
3,611 | 2,734 | ||||||
|
Amortization of deferred commissions |
10,453 | 9,190 | ||||||
|
Deferred income taxes |
5,220 | 5,055 | ||||||
|
Provision for credit losses |
193 | 568 | ||||||
|
Loss on equity method investments |
91 | 150 | ||||||
|
Other |
(548 | ) | (1,146 | ) | ||||
|
Changes in assets and liabilities: |
||||||||
|
Accounts and unbilled receivables |
49 | 1,033 | ||||||
|
Prepaid and other assets |
(9,984 | ) | (12,061 | ) | ||||
|
Accounts payable, accrued, and other liabilities |
(6,047 | ) | (4,739 | ) | ||||
|
Deferred revenue |
3,064 | 1,094 | ||||||
|
Net cash provided by operating activities |
57,958 | 50,127 | ||||||
|
Investing activities: |
||||||||
|
Cash paid for acquisitions |
(312 | ) | — | |||||
|
Purchases of marketable securities, net |
(34,818 | ) | (148 | ) | ||||
|
Purchase of other investments |
(2,700 | ) | (1,500 | ) | ||||
|
Purchases of property and equipment |
(1,980 | ) | (3,481 | ) | ||||
|
Payments associated with capitalized software development |
(21,329 | ) | (21,910 | ) | ||||
|
Net cash used in investing activities |
(61,139 | ) | (27,039 | ) | ||||
|
Financing activities: |
||||||||
|
Taxes paid related to net settlement of equity awards |
(786 | ) | (1,196 | ) | ||||
|
Payment of earn-outs related to acquisitions |
(446 | ) | — | |||||
|
Debt issuance costs |
(301 | ) | — | |||||
|
Payment of cash dividends |
(3,071 | ) | (2,809 | ) | ||||
|
Proceeds from issuance of common stock |
39,882 | — | ||||||
|
Repurchases of common stock |
(9,306 | ) | (25,018 | ) | ||||
|
Net cash provided by (used in) financing activities |
25,972 | (29,023 | ) | |||||
|
Effect of exchange rate changes on cash and cash equivalents |
12 | 10 | ||||||
|
Net increase (decrease) in cash and cash equivalents |
22,803 | (5,925 | ) | |||||
|
Cash and cash equivalents at beginning of period |
36,161 | 59,469 | ||||||
|
Cash and cash equivalents at end of period |
$ | 58,964 | $ | 53,544 | ||||
|
HealthStream Announces Third Quarter 2026 Results Page 8 November 2, 2026 |
|
Reconciliation of GAAP to Non-GAAP Financial Measures(1)
Operating Results Summary
(In thousands)
(Unaudited)
|
Three Months Ended September 30, |
Nine Months Ended September 30, |
|||||||||||||||
|
2026 |
2025 |
2026 |
2025 |
|||||||||||||
|
GAAP net income |
$ | 5,373 | $ | 6,086 | $ | 17,951 | $ | 15,808 | ||||||||
|
Interest income |
(510 | ) | (788 | ) | (1,399 | ) | (2,676 | ) | ||||||||
|
Interest expense |
26 | 26 | 76 | 76 | ||||||||||||
|
Income tax provision |
1,696 | 2,166 | 5,634 | 4,559 | ||||||||||||
|
Stock-based compensation expense |
1,196 | 794 | 3,611 | 2,734 | ||||||||||||
|
Depreciation and amortization |
11,265 | 10,820 | 33,905 | 32,441 | ||||||||||||
|
Fair value adjustment on contingent consideration |
— | — | (4 | ) | — | |||||||||||
|
Cybersecurity incident costs |
250 | — | 250 | — | ||||||||||||
|
Adjusted EBITDA |
$ | 19,296 | $ | 19,104 | $ | 60,024 | $ | 52,942 | ||||||||
(1) This press release presents adjusted EBITDA, which is a non-GAAP financial measure used by management in analyzing its financial results and ongoing operational performance.
|
HealthStream Announces Third Quarter 2026 Results Page 9 November 2, 2026 |
|
Reconciliation of GAAP to Non-GAAP Financial Measures
Financial Outlook for 2026
(In thousands)
(Unaudited)
|
Low |
High |
|||||||
|
Net income |
$ | 21,800 | $ | 22,400 | ||||
|
Interest income |
(2,200 | ) | (2,400 | ) | ||||
|
Interest expense |
100 | 100 | ||||||
|
Income tax provision |
6,900 | 7,100 | ||||||
|
Stock-based compensation expense |
5,000 | 5,200 | ||||||
|
Depreciation and amortization |
45,100 | 45,300 | ||||||
|
Cybersecurity incident costs |
300 | 300 | ||||||
|
Adjusted EBITDA |
$ | 77,000 | $ | 78,000 | ||||
|
HealthStream Announces Third Quarter 2026 Results Page 10 November 2, 2026 |
|
This press release includes certain forward-looking statements (statements other than solely with respect to historical fact), including statements regarding expectations for financial performance for 2026 and our quarterly dividend that involve risks and uncertainties regarding HealthStream. These statements are based upon management’s beliefs, as well as assumptions made by and data currently available to management. This information has been, or in the future may be, included in reliance on the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. The Company cautions that forward-looking statements involve known and unknown risks, uncertainties, and other factors that may cause the actual results, performance, or achievements to be materially different from future results, performance, or achievements expressed or implied by the forward-looking statements, including as a result of negative economic conditions, changes in U.S. policy, adverse developments impacting the technology and healthcare industries, tariff and trade-related developments, inflationary pressures, geopolitical instability, and legal requirements and contractual restrictions which may affect the continuation of our quarterly cash dividend policy and the declaration and/or payment of dividends thereunder, which may be modified, suspended, or canceled in any manner and at any time that our Board may deem necessary or appropriate, as well as risks referenced in the Company’s Annual Report on Form 10-K for the year ended December 31, 2025, filed on February 26, 2026, and in the Company’s other filings with the Securities and Exchange Commission from time to time. Consequently, such forward-looking information should not be regarded as a representation or warranty or statement by the Company that such projections will be realized. Many of the factors that will determine the Company’s future results are beyond the ability of the Company to control or predict. Readers should not place undue reliance on forward-looking statements, which reflect management’s views only as of the date hereof. The Company undertakes no obligation to update or revise any such forward-looking statements.
# # # #